`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`AMNEAL PHARAMCEUTICALS LLC and AMNEAL
`PHARMACEUTICALS OF NEW YORK, LLC,
`Petitioners,
`
`v.
`
`ALMIRALL, LLC,
`Patent Owner
`
`Case IPR2019-00207
`Patent 9,517,219
`
`POWER OF ATTORNEY FROM PATENT OWNER
`ALMIRALL, LLC
`
`
`
`IPR2019-00207
`
`Pursuant to 37 C.F.R. § 42.l0(b), Patent Owner, Almirall, LLC, hereby
`
`appoints the following lead and back-up counsel as its attorneys to transact all
`
`business in the United States Patent and Trademark Office associated with the
`
`above-captioned Inter Partes Review:
`
`LEAD COUNSEL
`
`James Trainor (Reg. No. 52,297)
`jtrainor@fenwick.com
`Postal and Hand Delivery Address
`Fenwick & West LLP
`902 Broadway, Suite 14
`New York, NY 10010
`(212) 430-2600 (tel)
`(650) 938-5200 (fax)
`
`BACK-UP COUNSEL
`
`Vanessa Park-Thompson (pro hac vice to be filed)
`vpark-thompson@fenwick.com
`Postal and Hand Delivery Address
`Fenwick & West LLP
`902 Broadway, Suite 14
`NewYork,NY 10010
`(212) 430-2691 (tel)
`(650) 938-5200 (fax)
`
`Elizabeth B. Hagen (pro hac vice to be filed)
`ehagen@fenwick.com
`Postal and Hand Delivery Address
`Fenwick & West LLP
`1191 Second A venue, 10th Floor
`Seattle, WA 98101
`(206) 389-4510 (tel)
`(206) 389-4511 (fax)
`
`2
`
`
`
`IPR2019-00207
`
`A statement under 37 C.F.R. § 3.73(c) is submitted herewith.
`
`The undersigned has the authority to execute this document on behalf of
`
`Patent Owner Almirall, LLC.
`
`Date: January 9, 2019
`
`Name: Ron Menezes
`
`Title: President and General Manager,
`
`Almirall, LLC
`
`3
`
`
`
`IPR2019-00207
`
`STATEMENT UNDER 37 C.F.R. § 3.73(c)
`
`Patent Owner: Almirall, LLC
`Patent No: 9,517,219
`Issue Date: Dec. 13, 2016
`Title: TOPICAL DAPSONE AND DAPSONE/ADAPLENE COMPOSITIONS
`AND METHODS FOR USE THEREOF
`
`Almirall, LLC, states that, for the patent identified above, it is the assignee of
`
`the entire right, title, and interest. That interest is evidenced by a chain of title from
`
`the inventors of the patent identified above to the current assignee as follows:
`
`1. Assignors: WARNER, KEVIN S. PARASHAR, AJAYP.
`
`Assignee: ALLERGAN, INC.
`
`Date Executed: Sept. 13, 2013
`
`Reel/Frame: 038398/0167
`
`2. Assignors: DOW PHARMACEUTICAL SCIENCES
`
`Assignees: ALLERGAN, INC.
`
`Date Executed: Nov. 13, 2013
`
`Reel/Frame: 038398/0213
`
`3. Assignors: BHATT, VARSHA SWAMINATHAN, VIJAYA
`
`Assignee: DOW PHARMACEUTICAL SCIENCES
`
`Date Executed: Nov. 13, 2013
`
`Reel/Frame: 038398/0200
`
`4. Assignors: PARASHAR, AJAYP. WARNER, KEVIN S.
`
`Assignee: ALLERGAN, INC.
`
`Date Executed: June 4, 2015
`
`4
`
`
`
`IPR2019-00207
`
`Reel/Frame: 038397/0920
`
`5. Assignors: BHATT, VARSHA SWAMINATHAN, VIJAYA
`
`Assignee: DOW PHARMACEUTICAL SCIENCES
`
`Date Executed: Nov. 9, 2015
`
`Reel/Frame: 038398/0001
`
`6. Assignor: DOW PHARMACEUTICAL SCIENCES
`
`Assignee: ALLERGAN, INC.
`
`Date Executed: Feb. 25, 2016
`
`Reel/Frame: 038398/0032
`
`7. Assignor: ALLERGAN, INC.
`
`Assignee: ALMIRALL, LLC
`
`Date Executed: Oct. 10, 2018
`
`Reel/Frame: 047132/0642
`
`The undersigned has the authority to execute this document on behalf of the
`
`assignee Almirall, LLC.
`
`Date: January 9, 2019
`
`Name: Ron Menezes
`
`Title: President and General Manager,
`
`Almirall, LLC
`
`5
`
`
`
`IPR2019-00207
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing Patent
`
`Owner Power of Attorney was served on February 5, 2019, by filing this
`
`document through the Patent Trial and Appeal Board End to End system as well as
`
`delivering a copy via electronic mail upon the following attorneys of record for the
`
`Petitioner:
`
`Dennies Carughese, Reg. No. 61,868
`dvarughe-ptab@sternekessler.com
`Adam LaRock, Reg. No. 64,681
`alarock-ptab@sternekessler.com
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`1100 New York Avenue, N.W.
`Washington, DC 20005-3934
`
`/James Trainor/
`James Trainor
`Reg. No. 52,297
`Phone: (212) 430-2600
`
`Date: February 5, 2019
`
`6
`
`